ESOTUS PLUS
Gentle Multi-Modal Support for Anxiety and Mood
Overview
ESOTUS PLUS is a balanced, low-dose fixed-dose combination (FDC) that integrates the world’s most selective SSRI with a high-potency anxiolytic. This formulation is specifically designed for patients who require a gentle start to therapy or for those who achieve clinical stability on a moderate dose of Escitalopram while still needing targeted relief from acute anxiety symptoms.
Key Composition
Each film-coated tablet contains:
- Escitalopram (5 mg): A highly refined Selective Serotonin Reuptake Inhibitor (SSRI). The 5 mg dose is ideal for stabilizing the serotonergic system with an extremely low side-effect profile.
- Clonazepam (0.5 mg): A potent benzodiazepine that acts quickly to soothe the central nervous system, providing rapid relief from panic, restlessness, and physical tension.
Mechanism of Action
ESOTUS PLUS provides comprehensive relief by acting on two primary pathways:
- The Serotonergic Pathway: Escitalopram optimizes the levels of serotonin in the brain, gradually improving mood, emotional resilience, and overall outlook.
- The GABAergic Pathway: Clonazepam enhances the inhibitory effects of GABA (Gamma-Aminobutyric Acid), providing an immediate "calming" effect that helps suppress the overactive "fight or flight" response.
The ESOTUS PLUS Advantage
- Precision Titration: The 5 mg/0.5 mg ratio allows clinicians to fine-tune therapy for sensitive patients.
- Immediate Symptom Control: Unlike SSRI monotherapy, ESOTUS PLUS begins working on physical anxiety symptoms almost immediately.
- Enhanced Tolerability: The refined dose of Escitalopram ensures a minimal impact on weight, sleep, and metabolic function.
- Bridging the Gap: Effectively manages symptoms during the 2–4 week window required for SSRIs to reach full clinical effect.
Dosage & Administration
As prescribed by a physician. Typically, one tablet is taken once daily. Due to the calming nature of Clonazepam, it is often recommended for evening or nighttime use, depending on the patient's specific anxiety patterns.